Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy

Acta Neuropathol Commun. 2018 Nov 5;6(1):118. doi: 10.1186/s40478-018-0622-1.

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
² Department of Pathology, Dell Children's Medical Center, Austin, TX, USA.
³ Neuro-Oncology Division, Dell Children's Medical Center, Austin, TX, USA.
⁴ Bioinformatics Research and Development Laboratory, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI, USA.
⁵ Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
⁶ Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. ida.cristiane@mayo.edu.

No abstract available

Keywords: BRAF; DIG; MAPK; Targeted therapy.

Publication types